On the other hand, PBRM-1-deficient tumors expressed increased cytokine pathway related genes such as IFN-γ, IL-2, IL-12, and CCL21, theoretically enhancing anti-tumor immunity. The gene discussed is IFNG; the disease is neoplasm.